News and ViewsRecent Price Performance and Market Context
The stock has outperformed its sector and benchmark indices significantly over the past week and month. In the last seven days, Ishita Drugs gained 9.92%, compared to the Sensex’s modest 0.42% rise. Similarly, over the past month, the stock appreciated by 9.83%, while the Sensex recorded only a 0.39% increase. This divergence highlights the stock’s relative strength in the current market environment.
Despite these short-term gains, the stock remains down 14.16% year-to-date and 5.55% over the last twelve months, contrasting with the Sensex’s positive returns of 9.51% and 9.64% respectively. However, the longer-term performance is more encouraging, with Ishita Drugs delivering a 50.12% return over three years and an impressive...
Read More
